Skip to main content
EXEL logo

Exelixis, Inc.

EXELNASDAQHealthcareBiotechnology

$62.23Today:- (-)1Y +60.08%

As of Oct 16, 2026 close

Market cap
$16.32B
P/E (TTM)
18.96
Forward P/E
13.89
Dividend yield
-
52-week range
$33.76$61.66
Volume (live)
-
Avg. volume (3M)
2.29M

Exelixis (EXEL) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Exelixis had a P/E ratio of 15.08 (down from 18.24), return on equity of 35.5% (up from 23.1%), debt-to-equity of 0.09 (down from 0.10) and a current ratio of 3.56 (down from 3.63). A current ratio of 3.56 means current assets exceed current liabilities.

Exelixis Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio15.0818.2435.9128.3825.0355.70
Forward P/E14.9518.0026.4628.4945.70-
P/S Ratio5.094.384.083.214.036.30
P/B Ratio5.464.243.292.082.623.31
Price/Tangible Book5.634.363.392.132.693.43
Price/FCF13.4714.1625.4715.4516.6934.86
Price/OCF13.3413.5922.3814.2714.4329.80
PEG Ratio0.530.500.890.831.0523.17
Enterprise Value Ratios
EV/Revenue4.493.693.582.353.095.15
EV/EBITDA11.2911.1233.3017.0314.7642.67
EV/EBIT11.6611.5838.3218.7915.4646.21
EV/FCF11.8811.9022.3611.3112.7928.47
Profitability & Returns
Return on Equity (ROE)35.53%23.13%8.74%7.76%11.30%6.27%
Return on Assets (ROA)19.26%14.64%3.55%4.43%7.54%3.42%
Return on Invested Capital (ROIC)55.98%37.25%9.60%14.33%29.54%11.69%
Return on Capital Employed (ROCE)36.60%27.10%6.70%7.30%12.60%5.70%
Leverage & Solvency Ratios
Debt/Equity0.090.100.100.080.030.03
Debt/EBITDA0.210.290.930.850.180.41
Debt/FCF0.230.320.740.620.160.29
Liquidity Ratios
Current Ratio3.563.633.344.995.437.06
Quick Ratio3.353.453.164.725.196.70
Efficiency Ratios
Asset Turnover0.800.740.610.570.600.49
Inventory Turnover3.803.842.871.912.182.14
Yield & Distribution Ratios
Earnings Yield6.63%5.48%2.79%3.52%4.00%1.80%
FCF Yield7.42%7.06%3.93%6.47%5.99%2.87%
Buyback Yield4.82%7.88%0.95%-0.68%-1.37%-0.95%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Exelixis Financial Ratios

What is Exelixis's P/E ratio?

Exelixis's P/E ratio was 15.08 for fiscal 2025 (period ended Dec 31, 2025). It was 18.24 a year earlier.

What is Exelixis's return on equity?

Exelixis's return on equity (ROE) was 35.5% for fiscal 2025 (period ended Dec 31, 2025). It was 23.1% a year earlier.

What is Exelixis's debt-to-equity ratio?

Exelixis's debt-to-equity ratio was 0.09 for fiscal 2025 (period ended Dec 31, 2025). It was 0.10 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition